These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33214781)

  • 1. Rapid Infliximab Infusion in the Pediatric Population.
    Munsel EJ; Bryan PJ; Binstadt BA; Bullock D; Correll CK; Downs EM; Hobday PM; Larson-Nath C; Sudel B; Vehe RK
    J Pediatr Pharmacol Ther; 2020; 25(8):705-708. PubMed ID: 33214781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Rapid vs Standard Infliximab Infusions in the Pediatric Population.
    Rozette NA; Hellauer CM; McKee C; Vazifedan T; Gabriel CA; Dice JE; Yokois NU
    Inflamm Bowel Dis; 2018 Aug; 24(9):2007-2014. PubMed ID: 29788416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated Infliximab Infusion: Safety, Factors Predicting Adverse Events, Patients' Satisfaction and Cost Analysis. A Cohort Study in IBD Patients.
    Mazzuoli S; Tricarico D; Demma F; Furneri G; Guglielmi FW
    PLoS One; 2016; 11(11):e0166443. PubMed ID: 27851772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Infliximab Infusion in Children: A Multicenter Retrospective Cohort Study.
    Lev-Tzion R; Assa A; Yerushalmi B; Lahad A; Friedman M; Ledder O; Turner D
    J Pediatr Gastroenterol Nutr; 2017 Nov; 65(5):e101-e103. PubMed ID: 29064928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are accelerated infliximab infusions safe in patients with inflammatory bowel disease?
    Bhat S; Sharma D; Doherty P; Tham TC; Caddy GR
    Inflamm Bowel Dis; 2010 Nov; 16(11):1922-5. PubMed ID: 20848465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability of one hour 10mg/kg infliximab infusions in inflammatory bowel diseases: a prospective multicenter cohort study.
    Babouri A; Roblin X; Filippi J; Hébuterne X; Bigard MA; Peyrin-Biroulet L
    J Crohns Colitis; 2014 Feb; 8(2):161-5. PubMed ID: 23994253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric rheumatology infusion center: report on therapeutic protocols and infusions given over 4 Years with focus on adverse events over 1 Year.
    Vinod SS; Reed AB; Maxwell J; Cron RQ; Stoll ML
    Pediatr Rheumatol Online J; 2018 Mar; 16(1):16. PubMed ID: 29523211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated Infliximab Infusion Safety and Tolerability Is Non-inferior to Standard Infusion Protocol in Inflammatory Bowel Disease Patients: A Randomized Controlled Study.
    Abushamma S; Walker T; Garza K; Chen L; Nix D; Chen CH
    Crohns Colitis 360; 2023 Jul; 5(3):otad022. PubMed ID: 37288326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated infliximab infusions are safe and well tolerated in patients with inflammatory bowel disease.
    Clare DF; Alexander FC; Mike S; Dan G; Allan F; Lisa W; Peter HJ
    Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):71-5. PubMed ID: 19060632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of rapid infliximab infusions on access at a large academic tertiary medical center.
    Pusateri A; Hatcher A; Patel N; Lehman J; Hinton A; Afzali A
    Am J Health Syst Pharm; 2021 Nov; 78(22):2046-2052. PubMed ID: 34050749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter retrospective experience of infliximab in Crohn's disease patients: infusion reaction rates and treatment persistency.
    Keshavarzian A; Mayer L; Salzberg B; Garone M; Finkelstein W; Cappa J; Brand M; Hain J; Zelinger D; Hegedus R; Diamond RH; Campbell U; Lane C; Stang P; Watson J; Cominelli F
    Gastroenterol Hepatol (N Y); 2007 May; 3(5):381-90. PubMed ID: 21960854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short article: Remicade infusions at home: an alternative setting of infliximab therapy for patients with Crohn's disease.
    Kuin S; Stolte SB; van den Brink GR; Ponsioen CY; Fockens P; D'Haens GR; Löwenberg M
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):222-5. PubMed ID: 26566062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability of one hour 10 mg/kg infliximab infusions in patients with inflammatory bowel disease.
    Babouri A; Buisson A; Bigard MA; Peyrin-Biroulet L
    J Crohns Colitis; 2013 Mar; 7(2):129-33. PubMed ID: 22472090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A home infliximab infusion program.
    Condino AA; Fidanza S; Hoffenberg EJ
    J Pediatr Gastroenterol Nutr; 2005 Jan; 40(1):67-9. PubMed ID: 15625429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid infliximab infusions in pediatric inflammatory bowel disease.
    Yeckes AR; Hoffenberg EJ
    J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):151-4. PubMed ID: 19516188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab for the treatment of psoriasis in the U.K.: 9 years' experience of infusion reactions at a single centre.
    Wee JS; Petrof G; Jackson K; Barker JN; Smith CH
    Br J Dermatol; 2012 Aug; 167(2):411-6. PubMed ID: 22404545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of acute adverse events related to infliximab infusions in pediatric patients.
    Lahdenne P; Wikström AM; Aalto K; Kolho KL
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):785-90. PubMed ID: 20535789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quality improvement project reduces time spent at an inflammatory bowel disease infusion center with accelerated infliximab infusion protocol.
    Ong WC; Lim MS; Chan E; Lim TCT; Lim TG; Chan W
    JGH Open; 2022 Jul; 6(7):470-476. PubMed ID: 35822121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BioAdvance Patient Support Program Survey: Positive Perception of Intravenous Infusions of Infliximab.
    Jones J; Borgaonkar M; Siffledeen J; O'Reilly R; Anger D; Dajnowiec D; Williamson M; Dyrda P
    Manag Care; 2017 Feb; 26(2):41-48. PubMed ID: 28273042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence and management of infusion reactions to infliximab in 186 italian patients with rheumatoid arthritis: the Padua experience].
    Botsios C; Ostuni P; Todesco S
    Reumatismo; 2005; 57(1):44-51. PubMed ID: 15776146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.